ATE185815T1 - Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen - Google Patents

Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen

Info

Publication number
ATE185815T1
ATE185815T1 AT93905796T AT93905796T ATE185815T1 AT E185815 T1 ATE185815 T1 AT E185815T1 AT 93905796 T AT93905796 T AT 93905796T AT 93905796 T AT93905796 T AT 93905796T AT E185815 T1 ATE185815 T1 AT E185815T1
Authority
AT
Austria
Prior art keywords
antigen
thermal
injury
icam
necrosis
Prior art date
Application number
AT93905796T
Other languages
English (en)
Inventor
Peter E Lipsky
William J Mileski
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE185815T1 publication Critical patent/ATE185815T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubricants (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT93905796T 1992-02-28 1993-02-05 Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen ATE185815T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84311292A 1992-02-28 1992-02-28

Publications (1)

Publication Number Publication Date
ATE185815T1 true ATE185815T1 (de) 1999-11-15

Family

ID=25289108

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93905796T ATE185815T1 (de) 1992-02-28 1993-02-05 Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen

Country Status (7)

Country Link
US (1) US6203793B1 (de)
EP (1) EP0628057B1 (de)
AT (1) ATE185815T1 (de)
AU (1) AU3657893A (de)
CA (1) CA2131190C (de)
DE (1) DE69326829D1 (de)
WO (1) WO1993017047A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695760A (en) * 1995-04-24 1997-12-09 Boehringer Inglehiem Pharmaceuticals, Inc. Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
WO1998006839A1 (en) * 1996-07-15 1998-02-19 Human Genome Sciences, Inc. Cd44-like protein
US6849712B1 (en) 1998-01-22 2005-02-01 Regents Of The University Of Minnesota Peptides with β1 integrin subunit dependent cell adhesion modulating activity
US6319942B1 (en) * 2001-06-06 2001-11-20 Nicholas V. Perricone Topical scar treatments using alkanolamines
CA2448596C (en) * 2001-06-06 2010-02-23 Nicholas V. Perricone Topical treatments using alkanolamines
EP1682537B1 (de) 2003-11-05 2012-03-28 SARcode Bioscience Inc. Modulatoren der zellulären adhäsion
AU2008317473B2 (en) 2007-10-19 2014-07-17 Bausch + Lomb Ireland Limited Compositions and methods for treatment of diabetic retinopathy
CN102056485A (zh) * 2008-04-15 2011-05-11 萨可德公司 用于局部治疗免疫相关疾病的局部lfa-1拮抗剂
US8437832B2 (en) * 2008-06-06 2013-05-07 Biosense Webster, Inc. Catheter with bendable tip
WO2015148971A2 (en) * 2014-03-27 2015-10-01 Research Foundation Of The City University Of New York Method for detecting or treating triple negative breast cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584089D1 (de) 1984-07-06 1991-10-17 Sandoz Ag Herstellung und reinigung von lymphokinen.
US4965271A (en) 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
ES2064327T3 (es) * 1987-11-02 1995-02-01 Baylor College Medicine Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
US5009889A (en) 1987-12-31 1991-04-23 Oklahoma Medical Research Foundation Treatment of dysfunctional vascular endothelium using activated protein C
DE69029336T2 (de) * 1989-03-09 1997-07-03 Center For Blood Research, Inc., Boston, Mass. Interzellulares Adhäsions-Molekül-2 und seine Bindungsliganden
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
WO1991019511A1 (en) * 1990-06-18 1991-12-26 The General Hospital Corporation CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS

Also Published As

Publication number Publication date
CA2131190A1 (en) 1993-09-02
EP0628057A4 (de) 1996-07-10
CA2131190C (en) 2008-08-12
DE69326829D1 (de) 1999-11-25
EP0628057B1 (de) 1999-10-20
AU3657893A (en) 1993-09-13
WO1993017047A1 (en) 1993-09-02
US6203793B1 (en) 2001-03-20
EP0628057A1 (de) 1994-12-14

Similar Documents

Publication Publication Date Title
Rochkind et al. Systemic effects of low‐power laser irradiation on the peripheral and central nervous system, cutaneous wounds, and burns
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
KR970702017A (ko) 콜라겐 치료 장치(collagen treatment apparatus)
DE69805202D1 (de) Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
ATE185815T1 (de) Verwendung einer therapeutischen zusammensetzungen zur behandlung von verbrennungen
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
Meirer et al. Shock wave therapy: an innovative treatment method for partial thickness burns
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
Derbyshire Observations on the treatment of ganglia with a report on hydrocortisone
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69407787D1 (de) Mischungen zur desodorisierung von tierexcrementen und entsprechendes verfahren zur desodorisierung
CAMPOS Treatment of bone cysts by intracavity injection of methylprednisolone acetate: a message to orthopedic surgeons.
Hinshaw et al. Effects of cortisone on the healing of disrupted abdominal wounds
Enwemeka Therapeutic light
Bayat et al. Low-level laser therapy improves early healing of medial collateral ligament injuries in rats
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
IRONS Jr et al. Soft-tissue coverage for the treatment of osteomyelitis of the lower part of the leg
Cheng et al. Coverage of wounds in the distal lower leg by advancement of an enlarged medial gastrocnemius skin flap
Rochkind et al. Low-energy laser irradiation and the nervous system: Method and results
RU2134134C1 (ru) Способ подготовки трансплантата для свободной аутодермопластики ожоговой раны
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties